Heartflow (NASDAQ:HTFL) Cut to “Hold” at Wall Street Zen

Wall Street Zen lowered shares of Heartflow (NASDAQ:HTFL) from a buy rating to a hold rating in a report published on Saturday morning,Wall Street Zen reports.

A number of other analysts have also weighed in on the company. Piper Sandler reissued an “overweight” rating and set a $64.00 price objective (up from $45.00) on shares of Heartflow in a research note on Tuesday, October 20th. Stifel Nicolaus upped their price target on shares of Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a report on Friday, August 14th. Morgan Stanley increased their price target on shares of Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a research report on Friday, August 14th. JPMorgan Chase & Co. boosted their price objective on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Finally, Wells Fargo & Company upped their price objective on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $48.62.

Heartflow Price Performance

Shares of NASDAQ HTFL opened at $56.66 on Friday. The business has a 50-day moving average of $51.45 and a 200-day moving average of $34.75. Heartflow has a 12 month low of $20.13 and a 12 month high of $60.56.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The firm had revenue of $64.08 million for the quarter. The business’s quarterly revenue was up 47.7% on a year-over-year basis. Analysts predict that Heartflow will post -0.75 earnings per share for the current fiscal year.

Insider Activity at Heartflow

In other Heartflow news, CEO John Farquhar sold 38,900 shares of the company’s stock in a transaction dated Monday, October 12th. The shares were sold at an average price of $49.57, for a total value of $1,928,273.00. Following the sale, the chief executive officer owned 283,014 shares in the company, valued at approximately $14,029,003.98. This represents a 12.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 23,933 shares of the firm’s stock in a transaction that occurred on Thursday, October 22nd. The shares were sold at an average price of $55.01, for a total transaction of $1,316,554.33. Following the transaction, the insider directly owned 73,453 shares of the company’s stock, valued at $4,040,649.53. This represents a 24.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 305,476 shares of company stock valued at $14,851,624 in the last three months. Company insiders own 7.70% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. GAMMA Investing LLC boosted its position in shares of Heartflow by 75.1% during the third quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock valued at $32,000 after buying an additional 275 shares during the last quarter. Allworth Financial LP grew its holdings in Heartflow by 116.4% during the 3rd quarter. Allworth Financial LP now owns 1,145 shares of the company’s stock valued at $57,000 after buying an additional 616 shares in the last quarter. IFP Advisors Inc raised its position in shares of Heartflow by 844.7% during the third quarter. IFP Advisors Inc now owns 803 shares of the company’s stock valued at $40,000 after buying an additional 718 shares during the last quarter. Strs Ohio boosted its position in shares of Heartflow by 35.3% during the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock worth $112,000 after acquiring an additional 1,200 shares during the last quarter. Finally, Integrated Wealth Concepts LLC bought a new position in shares of Heartflow during the second quarter worth $53,000.

About Heartflow

HeartFlow, Inc is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning.

The company’s offerings include HeartFlow FFR_CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque.